Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon
Authors:
- Marta García-GraneroMGMarta García-Granero
- José I. Riezu-BojJRJosé I. Riezu-Boj
- Esther LarreaELEsther Larrea
- Enrique de AlavaEAEnrique de Alava
- María P. CiveiraMCMaría P. Civeira
- Alberto CastillaACAlberto Castilla
- Jesús PrietoJPJesús Prieto
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 21 (1) , 4-11
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Randomised trial of lymphoblastoid α-interferon in chronic hepatitis C: Effects on inflammation, fibrogenesis and viremiaJournal of Hepatology, 1993
- Histological outcome of chronic hepatitis C treated with a 12‐month course of lymphoblastoid alfa interferonLiver International, 1993
- Replication of hepatitis C virus in peripheral blood mononuclear cellsJournal of Hepatology, 1992
- Interferon for non-A, non-B chronic hepatitisJournal of Hepatology, 1991
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991
- Studies on the Composition of the Mononuclear Cell Infiltrates in Liver From Patients With Chronic Active Delta HepatitisHepatology, 1989
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981